Wednesday, 26 May 2021

Global In-vitro Fertilization Market Research Report

 The data examined by GME predicted that by 2026, the Global In-vitro Fertilization Market would grow with a CAGR value of 10.9 percent and cross USD xx Million. Growing reproductive tourism in Asian countries and the high prevalence of male and female infertility are two main factors boosting the market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-in-vitro-fertilization-market-3186

By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor), By End-Use (Hospitals & Others Setting, Fertility Clinics), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Key Market Insights

·         In vitro fertilization (IVF) is a set of procedures that are specifically intended to aid in pregnancy, prevent genetic defects, and facilitate childbirth.

·         Because of variables such as funding availability and an improvement in research activities to develop culture media, the culture media category led to the increased demand for IVF and contributed to the highest profit share during 2021-2026

·         During the projected era, the fresh non-donor category led the IVF segment and contributed to the highest revenue globally.

·         Cooper Surgical Inc., Thermo Fisher Scientific Inc., OvaScience, Cook Medical Inc, Vitrolife AB, Irvine Scientific, Progyny, Inc., EMD Serono Inc., Boston IVF, and Genea Biomedx are some of the major players in the in-vitro fertilization market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-in-vitro-fertilization-market-3186

Instrument Outlook (Revenue, USD Million, 2021-2026)

·         Disposable Devices

·         Culture Media

Procedure Type Outlook (Revenue, USD Million, 2021-2026)

·         Fresh Donor

·         Fresh Non-donor

·         Frozen Donor

·         Frozen Non-donor

End-Use Outlook (Revenue, USD Million, 2021-2026)

·         Hospitals & Others Setting

·         Fertility Clinics

Regional Outlook (Revenue, USD Million, 2021-2026)

North America                                                                                 

  • The U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Rest of MEA

 

Contact: Tracy Simon

Email address: tracy.simon@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

No comments:

Post a Comment